Literature DB >> 33532250

Aortic dissection assessment by 4D phase-contrast MRI with hemodynamic parameters: the impact of stent type.

Chien-Wei Chen1,2, Yuan-Hsi Tseng3,4, Chien-Chao Lin3,4, Chih-Chen Kao3,4, Min Yi Wong3, Hua Ting1, Yao-Kuang Huang3,4.   

Abstract

BACKGROUND: To explore the diagnostic performance of 4-dimensional phase-contrast magnetic resonance imaging (4D PC-MRI) in evaluating aortic dissection in different clinical scenarios.
METHODS: The study group comprised 32 patients with a known aortic dissection who each underwent computed tomography angiography (CTA), and then 4D PC-MRI with a 1.5-T MR scanner. The 4D PC-MRI images were compared with the CTA images to evaluate the aortic size, branch identification, and iliac and femoral arterial access.
RESULTS: The patients were divided into three groups: (I) patients diagnosed with Type B aortic dissection but did not undergo intervention (n=8); (II) patients with residual aortic dissection after open repair of Type A dissection (n=7); (III) patients who underwent endovascular aortic repair with or without open surgery (n=17). Without radiation or contrast media injection, 4D PC-MRI provided similar aortic images for patients in Group 1 and most of those in Group 2. In Group 3, stainless steel stents affected image quality in three patients. High-quality 4D PC-MRI images were obtained for the remaining 14 patients in Group 3, who had non-stainless steel stents, and provided major aortic information comparable to that provided by CTA with contrast media. The hemodynamic parameters of true and false lumens were evaluated between three patients with Type B aortic dissections and three patients who underwent thoracic endovascular aortic repair for their aortic dissection. The stroke volume was higher in the true lumen of the patients with stent-grafts than in the patients with Type B aortic dissection without intervention. The regurgitant fraction, an indicator of nonlaminar flow, was higher in the false lumens than in the true lumens. All 32 patients in this study tolerated 4D PC-MRI without adverse events.
CONCLUSIONS: 4D PC-MRI is radiation- and contrast media-free option for imaging aortic dissection. It not only provided images comparable in quality to those obtained with CTA but also provided information on hemodynamic parameters, including endoleak detection after thoracic endovascular aortic repair. 4D PC-MRI was safe and accurate in evaluating chronic Type B aortic dissection and residual aortic dissection after surgery for acute Type A aortic dissection. Therefore, it could be a potential tool in treating pathology in aortic dissection, especially for patients with malperfusion syndrome of visceral vessels and in young patients with renal function impairment. However, certain endograft materials, especially stainless steel, may prevent the further application of 4D PC-MRI and should be avoided. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  4-dimensional imaging; aortic dissection, endovascular repair; magnetic resonance imaging (MRI); malperfusion; non-contrast imaging

Year:  2021        PMID: 33532250      PMCID: PMC7779903          DOI: 10.21037/qims-20-670

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  29 in total

Review 1.  CT imaging for acute aortic syndrome.

Authors:  Andrew D Smith; Paul Schoenhagen
Journal:  Cleve Clin J Med       Date:  2008-01       Impact factor: 2.321

Review 2.  Multidetector CT of Aortic Dissection: A Pictorial Review.

Authors:  Michelle A McMahon; Christopher A Squirrell
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

3.  Magnetic resonance angiography of the origins of the supraaortic arteries: comparison of single and double volume acquisition 3D time of flight.

Authors:  A Carriero; N Magarelli; F Padovano; M Baratto; R Fossaceca; L Bonomo
Journal:  J Neuroradiol       Date:  1996-09       Impact factor: 3.447

Review 4.  Endovascular approach for acute aortic syndrome.

Authors:  M Di Eusanio; V Russo; K Buttazzi; L Lovato; R Di Bartolomeo; R Fattori
Journal:  J Cardiovasc Surg (Torino)       Date:  2010-06       Impact factor: 1.888

Review 5.  Toxicity of MRI and CT contrast agents.

Authors:  Kendra M Hasebroock; Natalie J Serkova
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-04       Impact factor: 4.481

Review 6.  Intramural hematoma and penetrating ulcers: indications to endovascular treatment.

Authors:  H Eggebrecht; B Plicht; P Kahlert; R Erbel
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-10-02       Impact factor: 7.069

7.  4D-Flow MRI: Technique and Applications.

Authors:  Alexandra Sträter; Armin Huber; Jan Rudolph; Maria Berndt; Michael Rasper; Ernst J Rummeny; Jonathan Nadjiri
Journal:  Rofo       Date:  2018-08-13

8.  Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.

Authors:  Aurang Z Khawaja; Deirdre B Cassidy; Julien Al Shakarchi; Damian G McGrogan; Nicholas G Inston; Robert G Jones
Journal:  Insights Imaging       Date:  2015-08-08

9.  Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.

Authors:  Nicola Schieda; Jason I Blaichman; Andreu F Costa; Rafael Glikstein; Casey Hurrell; Matthew James; Pejman Jabehdar Maralani; Wael Shabana; An Tang; Anne Tsampalieros; Christian B van der Pol; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2018-06-12

10.  Image quality and pathology assessment in CT Urography: when is the low-dose series sufficient?

Authors:  Bharti Kataria; Jonas Nilsson Althén; Örjan Smedby; Anders Persson; Hannibal Sökjer; Michael Sandborg
Journal:  BMC Med Imaging       Date:  2019-08-09       Impact factor: 1.930

View more
  1 in total

1.  Can invasive diagnostic methods be reduced by magnetic resonance imaging in the diagnosis of diaphragmatic injuries in left thoracoabdominal penetrating injuries?

Authors:  Elchin Alizade; Mehmet İlhan; Görkem Durak; Ali Fuat Kaan Gok; Cemalettin Ertekin
Journal:  J Minim Access Surg       Date:  2022 Jul-Sep       Impact factor: 1.018

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.